Carmen Almansa-Rosales

Title: Carmen Almansa-Rosales: A Catalyst for Innovations in Medicine

Introduction:

Carmen Almansa-Rosales, an accomplished inventor hailing from Barcelona, ES, has made significant contributions to the field of pharmaceuticals and drug research. With an impressive portfolio of 34 patents, Almansa-Rosales has been at the forefront of developing novel compounds to combat drug abuse, addiction, pain, and related conditions. This article explores his latest patents, career highlights, and notable collaborations, shedding light on his invaluable contributions to the field.

Latest Patents:

Two of Carmen Almansa-Rosales' recent patents have garnered considerable attention for their potential in treating drug abuse, addiction, and pain-related conditions:

1. Oxadiazaspiro compounds for the treatment of drug abuse and addiction:

This patent focuses on compounds that exhibit pharmacological activity towards the sigma (σ) receptor. Specifically, Almansa-Rosales has discovered oxadiazaspiro compounds with this activity, along with their preparation processes, pharmaceutical compositions, and therapeutic applications against drug abuse and addiction.

2. Alcoxyamino derivatives for treating pain and pain-related conditions:

In this patent, Almansa-Rosales unveils novel compounds with high affinity and activity towards the subunit α2δ of voltage-gated calcium channels (VGCC) and possibly the noradrenaline transporter (NET). The invention also details the compound's preparation processes, medicinal compositions, and potential applications in pain management.

Career Highlights:

Carmen Almansa-Rosales has made significant professional strides throughout his career, contributing to renowned pharmaceutical companies such as Esteve Pharmaceuticals, S.A. and Laboratorios del Dr. Esteve S.A. (now referred to as Laboratorios ESTEVE). His expertise in innovative compound development and dedication to advancing medical science have earned him recognition within the industry.

Collaborations:

Almansa-Rosales has had the privilege of collaborating with esteemed individuals in the field, notably Marina Virgili-Bernado and Carlos Alegret-Molina. Together, they have pushed the boundaries of pharmaceutical research, pooling their expertise and knowledge to develop groundbreaking solutions for pressing medical challenges.

Conclusion:

Carmen Almansa-Rosales has solidified his position as a trailblazer in the world of pharmaceutical research, with an exceptional record of 34 patents to his name. Through his relentless pursuit of innovative solutions, Almansa-Rosales has contributed significantly to the development of compounds aimed at addressing drug abuse, addiction, and pain-related conditions. His collaborations with esteemed colleagues further exemplify his dedication to fostering advancements in medical science. Carmen Almansa-Rosales serves as an inspiration and catalyst for future innovators, driving us closer to a better and healthier world.